Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.

导出 OA

翻译打印收藏纠错

第一作者： Carlos,Rondon-Clavo

第一单位： Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

作者： Carlos,Rondon-Clavo ^[1] ; Michael,Scordo ^[2] ; Patrick,Hilden ^[3] ; Gunjan L,Shah ^[4] ; Christina,Cho ^[4] ; Molly A,Maloy ^[1] ; Esperanza B,Papadopoulos ^[4] ; Ann A,Jakubowski ^[4] ; Richard J,O'Reilly ^[5] ; Boglarka,Gyurkocza ^[4] ; Hugo,Castro-Malaspina ^[4] ; Roni,Tamari ^[4] ; Brian C,Shaffer ^[4] ; Miguel-Angel,Perales ^[4] ; Edgar A,Jaimes ^[6] ; Sergio A,Giralt ^[4]

作者单位： Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. ^[1] Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address: scordom@mskcc.org. ^[2] Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. ^[3] Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. ^[4] Pediatric Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pediatrics, Weill Cornell Medical College, New York, New York. ^[5] Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Renal Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. ^[6]

关键词 Ex vivo CD34-selected allogeneic transplantation Fluid overload Nonrelapse mortality Toxicity